Some medical device businesses not only survived the COVID-19 pandemic but actually thrived — with many producing the medtech needed to fight the coronavirus’s spread. Medical Design & Outsourcing recently analyzed financials for 20 of the largest medical device businesses in the world. Not only was revenue only slightly down for the 20 during 2020, but it was […]
Alcon
How big medtech fared during a year of COVID-19
Despite numerous challenges, the medtech industry showed itself to be fairly recession-proof in 2020, according to a Medical Design & Outsourcing/MassDevice analysis of financials. Annual reports recently released by 20 of the world’s largest medical device companies showed only a slight dip in revenue during 2020 — a year in which medtech held the front lines against […]
Alcon launches extended depth of focus intraocular lens
Alcon (NYSE:ALC) announced today that it launched the first and only non-diffractive extended depth of focus intraocular lens in the U.S. Geneva, Switzerland-based Alcon’s AcrySof IQ Vivity IOL, a presbyopia-mitigating lens, is now available to all U.S. ophthalmologists for use with patients who are undergoing cataract surgery, according to a news release. AcrySof IQ Vivity uses […]
The 20 largest medical device companies in the world
The information in this year’s annual Big 100 rankings of the world’s largest medical device companies is as interesting as ever. The 100 companies on this year’s list had medical device businesses bringing in a whopping $420.5 billion during their most recent fiscal years — a nearly 6% increase from the 2019 Big 100. But […]
Diversity in medtech: Just 20% of executive roles held by women
Diversity in executive roles in the medical device industry is trending more toward parity, with women holding 2% more C-suite roles in 2020 compared to last year. Just 20% of executives at the 100 largest medical device companies in the world are women, and those companies average 19% female composition in the C-suite, according to […]
Alcon slides on missed Q2 earnings
Alcon (NYSE:ALC) shares dipped before hours today on second-quarter results that missed the consensus earnings forecast. The Geneva, Switzerland-based company posted losses of -$422 million, or -86¢ per share, on sales of $1.2 billion for the three months ended June 30, 2020, for an 8.2% bottom-line slide on a sales decline of -36.2%. Adjusted to exclude […]
Novartis, Alexion charged with FPCA violations
Novartis (NYSE:NVS) and Alexion Pharmaceuticals (NSDQ:ALXN) were charged with violations of the books and records and internal accounting controls provisions of the Foreign Corrupt Practices Act (FCPA). The Securities & Exchange Commission (SEC) announced that the pharmaceutical companies both committed violations and both agreed to pay millions of dollars to settle the charges. Novartis settled to pay over […]
Alcon prices $750m public offering
Alcon (NYSE:ALC) announced that it commenced and priced a private offering of senior notes worth a total of $750 million. The Geneva, Switzerland-based vision care company is offering 2.6% senior notes due in 2030. The notes will be issued by Alcon Finance Corporation, an indirect subsidiary. They will be fully and unconditionally guaranteed on a senior […]
Medtech 100 roundup: Stocks dip slightly after strong start to month
Medtech stocks ticked down over the course of last week as the COVID-19 pandemic continues to bear economic ramifications. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — sat at 82.4 points at the end of last week (May 15). That total represents a -1.9% decline from the 83.98-point […]
Alcon rises on Street-beating Q1 results
Alcon (NYSE:ALC) shares boomed today on first-quarter financial results that came in well above the consensus forecast. Shares of ALC shot up 7.6% at $57.22 per share in early-morning trading today, following yesterday’s release of the company’s earnings report. The Geneva, Switzerland-based vision care company posted losses of -$57 million, or -12¢ per share, on sales […]
How will coronavirus affect medtech companies that rely on elective surgeries?
One thing is likely to hurt some medtech companies more than others during the coronavirus pandemic: an elective surgical procedure slowdown. This thought had begun to emerge last week among industry watchers, but a pair of tweets over the weekend gained thousands of “likes” and retweets. The American College of Surgeons called for hospitals to […]
